|
| 36793435 | Discovery of OICR12694: A Novel, Potent, Selective, and Orally Bioavailable BCL6 BTB Inhibitor. | ACS Med Chem Lett | 2023 |
| 34963044 | Correction to "Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma". | J Med Chem | 2022 |
| 34055235 | Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of <sup>11</sup>C-Labeled ALK2 Inhibitors. | ACS Med Chem Lett | 2021 |
| 34589290 | The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia. | Oncoimmunology | 2021 |
| 34662547 | Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells. | J Mol Biol | 2021 |
| 34291633 | Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma. | J Med Chem | 2021 |
| 32369358 | Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. | J Med Chem | 2020 |
| 32758183 | Antagonists of the serotonin receptor 5A target human breast tumor initiating cells. | BMC Cancer | 2020 |
| 32295120 | Sorafenib as an Inhibitor of RUVBL2. | Biomolecules | 2020 |
| 26952093 | PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. | J Transl Med | 2016 |
| 22160482 | A small molecule screening strategy with validation on human leukemia stem cells uncovers the therapeutic efficacy of kinetin riboside. | Blood | 2012 |
| 23046966 | Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development. | Bioorg Med Chem Lett | 2012 |
| 23074266 | TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway. | Sci Signal | 2012 |
| 21303981 | Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells. | Cancer Res | 2011 |
| 22014571 | Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death. | Cancer Cell | 2011 |
| 22009536 | Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers. | Cancer Res | 2011 |
| 21601509 | The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms. | Drug Resist Updat | 2011 |
| 21067920 | 4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators. | Bioorg Med Chem Lett | 2010 |
| 19501602 | Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice. | Neuropharmacology | 2009 |
| 19818346 | The anti-epileptic drug lacosamide (Vimpat) has anxiolytic property in rodents. | Eur J Pharmacol | 2009 |
| 15638778 | Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs. | Curr Top Med Chem | 2005 |
| 16178734 | Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications. | Curr Top Med Chem | 2005 |
| 14643336 | Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists. | Bioorg Med Chem Lett | 2003 |
| 12161155 | 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands. | Bioorg Med Chem Lett | 2002 |
| 11378357 | 5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors. | Bioorg Med Chem Lett | 2001 |
| 16032481 | Recent advances in 5-HT(1D)-selective agonists. | IDrugs | 2001 |
| 10937732 | 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists. | Bioorg Med Chem Lett | 2000 |
| 10853660 | Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesity. | Bioorg Med Chem Lett | 2000 |
| 11671726 | Factors Influencing 1,4-Asymmetric Induction during Indium-Promoted Coupling of Oxygen-Substituted Allylic Bromides to Aldehydes in Aqueous Solution. | J Org Chem | 1997 |
| 11671749 | Diastereoselection during 1,2-Addition of the Allylindium Reagent to alpha-Thia and alpha-Amino Aldehydes in Aqueous and Organic Solvents. | J Org Chem | 1997 |